A citation-based method for searching scientific literature

Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann M Henry, Steven Joniau, Thomas B Lam, Malcolm D Mason, Vsevolod B Matveev, Paul C Moldovan, Roderick C N van den Bergh, Thomas Van den Broeck, Henk G van der Poel, Theo H van der Kwast, Olivier Rouvière, Ivo G Schoots, Thomas Wiegel, Philip Cornford. Eur Urol 2017
Times Cited: 1882







List of co-cited articles
276 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.
Jeffrey C Weinreb, Jelle O Barentsz, Peter L Choyke, Francois Cornud, Masoom A Haider, Katarzyna J Macura, Daniel Margolis, Mitchell D Schnall, Faina Shtern, Clare M Tempany,[...]. Eur Urol 2016
13

ESUR prostate MR guidelines 2012.
Jelle O Barentsz, Jonathan Richenberg, Richard Clements, Peter Choyke, Sadhna Verma, Geert Villeirs, Olivier Rouviere, Vibeke Logager, Jurgen J Fütterer. Eur Radiol 2012
12

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
12

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
A V D'Amico, R Whittington, S B Malkowicz, D Schultz, K Blank, G A Broderick, J E Tomaszewski, A A Renshaw, I Kaplan, C J Beard,[...]. JAMA 1998
10

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Alberto Briganti, Alessandro Larcher, Firas Abdollah, Umberto Capitanio, Andrea Gallina, Nazareno Suardi, Marco Bianchi, Maxine Sun, Massimo Freschi, Andrea Salonia,[...]. Eur Urol 2012
429
9

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Hashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, Rhian Gabe, Richard Kaplan, Mahesh K Parmar, Yolanda Collaco-Moraes, Katie Ward, Richard G Hindley, Alex Freeman,[...]. Lancet 2017
9

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.
Baris Turkbey, Andrew B Rosenkrantz, Masoom A Haider, Anwar R Padhani, Geert Villeirs, Katarzyna J Macura, Clare M Tempany, Peter L Choyke, Francois Cornud, Daniel J Margolis,[...]. Eur Urol 2019
575
8

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, Malcolm Mason, Chris Metcalfe, Peter Holding, Michael Davis, Tim J Peters, Emma L Turner, Richard M Martin,[...]. N Engl J Med 2016
8

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Veeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A Mynderse, Markku H Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G Hindley,[...]. N Engl J Med 2018
8

Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.
Maarten de Rooij, Esther H J Hamoen, J Alfred Witjes, Jelle O Barentsz, Maroeska M Rovers. Eur Urol 2016
312
7

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen,[...]. Eur Urol 2021
403
7

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
6


EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F Zattoni,[...]. Eur Urol 2014
5

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
601
5

The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Nicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, Roderick C N van den Bergh, Cathy Yuhong Yuan, Erik Briers, Joaquim Bellmunt, Michel Bolla, Philip Cornford, Maria De Santis,[...]. Eur Urol 2017
186
5

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad M Martin, Mark Frydenberg, Ramdave Shakher,[...]. Lancet 2020
476
5

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
5


A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Leonard P Bokhorst, Riccardo Valdagni, Antti Rannikko, Yoshiyuki Kakehi, Tom Pickles, Chris H Bangma, Monique J Roobol. Eur Urol 2016
204
5

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.
Jeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, Patricia Landis, Sacha Wolf, Bruce J Trock, H Ballentine Carter. J Clin Oncol 2015
345
5

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
Laurence Klotz, Danny Vesprini, Perakaa Sethukavalan, Vibhuti Jethava, Liying Zhang, Suneil Jain, Toshihiro Yamamoto, Alexandre Mamedov, Andrew Loblaw. J Clin Oncol 2015
744
5

Multiparametric MRI - local staging of prostate cancer and beyond.
Iztok Caglic, Viljem Kovac, Tristan Barrett. Radiol Oncol 2019
22
18

The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, Agostino Mattei, Cristian Fiori, Mathieu Roumiguié, Nicola Fossati, Armando Stabile, Jean-Baptiste Beauval, Bernard Malavaud,[...]. Eur Urol 2020
41
9

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Marloes van der Leest, Erik Cornel, Bas Israël, Rianne Hendriks, Anwar R Padhani, Martijn Hoogenboom, Patrik Zamecnik, Dirk Bakker, Anglita Yanti Setiasti, Jeroen Veltman,[...]. Eur Urol 2019
313
4

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, Ronald C Chen, Tony Crispino, Joann Fontanarosa, Stephen J Freedland, Kirsten Greene, Laurence H Klotz, Danil V Makarov,[...]. J Urol 2018
177
4

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
Marc A Bjurlin, Peter R Carroll, Scott Eggener, Pat F Fulgham, Daniel J Margolis, Peter A Pinto, Andrew B Rosenkrantz, Jonathan N Rubenstein, Daniel B Rukstalis, Samir S Taneja,[...]. J Urol 2020
75
5

Prostate cancer radiomics and the promise of radiogenomics.
Radka Stoyanova, Mandeep Takhar, Yohann Tschudi, John C Ford, Gabriel Solórzano, Nicholas Erho, Yoganand Balagurunathan, Sanoj Punnen, Elai Davicioni, Robert J Gillies,[...]. Transl Cancer Res 2016
70
5

Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
Caroline M Moore, Francesco Giganti, Peter Albertsen, Clare Allen, Chris Bangma, Alberto Briganti, Peter Carroll, Masoom Haider, Veeru Kasivisvanathan, Alex Kirkham,[...]. Eur Urol 2017
125
4

ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
Maarten de Rooij, Bas Israël, Marcia Tummers, Hashim U Ahmed, Tristan Barrett, Francesco Giganti, Bernd Hamm, Vibeke Løgager, Anwar Padhani, Valeria Panebianco,[...]. Eur Radiol 2020
88
4

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Olivier Rouvière, Philippe Puech, Raphaële Renard-Penna, Michel Claudon, Catherine Roy, Florence Mège-Lechevallier, Myriam Decaussin-Petrucci, Marine Dubreuil-Chambardel, Laurent Magaud, Laurent Remontet,[...]. Lancet Oncol 2019
402
4

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Thomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, Tobias Gross, Lisa Moris, Erik Briers, Marcus Cumberbatch, Maria De Santis, Derya Tilki, Stefano Fanti,[...]. Eur Urol 2019
134
4

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, Ronald C Chen, Tony Crispino, Joann Fontanarosa, Stephen J Freedland, Kirsten Greene, Laurence H Klotz, Danil V Makarov,[...]. J Urol 2018
397
4

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Jonathan I Epstein, William C Allsbrook, Mahul B Amin, Lars L Egevad. Am J Surg Pathol 2005
4

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
4

Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy.
Lars Budäus, Sami-Ramzi Leyh-Bannurah, Georg Salomon, Uwe Michl, Hans Heinzer, Hartwig Huland, Markus Graefen, Thomas Steuber, Clemens Rosenbaum. Eur Urol 2016
288
3


Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Jeffrey J Tosoian, Meera Chappidi, Zhaoyong Feng, Elizabeth B Humphreys, Misop Han, Christian P Pavlovich, Jonathan I Epstein, Alan W Partin, Bruce J Trock. BJU Int 2017
62
4

Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
Makoto Ohori, Michael W Kattan, Hideshige Koh, Norio Maru, Kevin M Slawin, Shahrokh Shariat, Masatoshi Muramoto, Victor E Reuter, Thomas M Wheeler, Peter T Scardino. J Urol 2004
219
3

Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
Alberto Martini, Akriti Gupta, Sara C Lewis, Shivaram Cumarasamy, Kenneth G Haines, Alberto Briganti, Francesco Montorsi, Ashutosh K Tewari. BJU Int 2018
57
5

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Kareem N Rayn, Jonathan B Bloom, Samuel A Gold, Graham R Hale, Joseph A Baiocco, Sherif Mehralivand, Marcin Czarniecki, Vikram K Sabarwal, Vladimir Valera, Bradford J Wood,[...]. J Urol 2018
45
6

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
D M Somford, E H Hamoen, J J Fütterer, J P van Basten, C A Hulsbergen-van de Kaa, W Vreuls, I M van Oort, H Vergunst, L A Kiemeney, J O Barentsz,[...]. J Urol 2013
138
3

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
3

Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.
Brandon A Mahal, Santino Butler, Idalid Franco, Daniel E Spratt, Timothy R Rebbeck, Anthony V D'Amico, Paul L Nguyen. JAMA 2019
107
3

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.
John W Yaxley, Geoffrey D Coughlin, Suzanne K Chambers, Stefano Occhipinti, Hema Samaratunga, Leah Zajdlewicz, Nigel Dunglison, Rob Carter, Scott Williams, Diane J Payton,[...]. Lancet 2016
362
3

Active surveillance for prostate cancer: a systematic review of the literature.
Marc A Dall'Era, Peter C Albertsen, Christopher Bangma, Peter R Carroll, H Ballentine Carter, Matthew R Cooperberg, Stephen J Freedland, Laurence H Klotz, Christopher Parker, Mark S Soloway. Eur Urol 2012
443
3


Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.
Justin E Bekelman, R Bryan Rumble, Ronald C Chen, Thomas M Pisansky, Antonio Finelli, Andrew Feifer, Paul L Nguyen, D Andrew Loblaw, Scott T Tagawa, Silke Gillessen,[...]. J Clin Oncol 2018
75
4

Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
Matthew R Cooperberg, Yingye Zheng, Anna V Faino, Lisa F Newcomb, Kehao Zhu, Janet E Cowan, James D Brooks, Atreya Dash, Martin E Gleave, Frances Martin,[...]. JAMA Oncol 2020
12
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.